Harold DeMonaco reviews a recent commentary on cancer drug costs and concludes that journalists should do better: "The good news is that newer drugs can prolong lifespan and improve the quality of life of cancer patients. The bad news is that these drugs are rapidly becoming unaffordable to the average American. In many instances, health care journalists don’t seem to be telling their readers about the rising cost of these drugs and what that trend means for patients."
September 10, 2015
.png)
